Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 May;53(5):1969-1980.
doi: 10.1007/s10508-023-02773-6. Epub 2023 Dec 26.

Systematic Review on Gender-Affirming Testosterone Therapy and the Risk of Breast Cancer: A Challenge for Physicians Treating Patients from Transgender and Gender-Diverse Populations

Saagar Pamulapati  1 , Meghan Conroy  2 , Chandler Cortina  2 , Eric Harding  3 , Sailaja Kamaraju  2
Affiliations

Systematic Review on Gender-Affirming Testosterone Therapy and the Risk of Breast Cancer: A Challenge for Physicians Treating Patients from Transgender and Gender-Diverse Populations

Saagar Pamulapati et al. Arch Sex Behav. 2024 May.

Abstract

Conflicting evidence exists about the risk of breast cancer in transgender and gender-diverse (TGD) patients treated with testosterone. This review aimed to summarize current knowledge regarding the risk of breast cancer associated with gender-affirming testosterone treatment (GATT). A systematic literature search using the Preferred Reporting Items for Systematic Review and Meta-Analysis checklist was conducted in January 2023 through Ovid, Scopus, and Web of Science databases. English-language, peer-reviewed articles evaluating breast cancer in TGD patients after GATT that met the inclusion criteria were included. This review included 22 articles, with 14 case reports, 4 case series, and 4 retrospective cohort studies. The review identified 26 TGD patients who developed breast cancer post-GATT therapy, with inconclusive evidence on the relationship between testosterone and the risk of breast cancer in TGD patients. This uncertainty in part arises from the mechanisms governing testosterone's effects within breast tissue, with contrasting theories proposing both proliferative and antiproliferative impacts. Considering this ambiguity, it is imperative for healthcare providers to engage in informed discussions with patients prior to initiating hormone therapy to discuss potential adverse effects, including the possibility of breast cancer development in TGD individuals. Patient education and shared decision-making are essential components of responsible care in this context.

Keywords: Breast cancer; Gender-affirming hormone therapy; Gender-diverse; Hormone replacement therapy; Testosterone; Transgender.

PubMed Disclaimer

References

    1. Akhavan, A. A., Sandhu, S., Ndem, I., & Ogunleye, A. A. (2021). A review of gender affirmation surgery: What we know, and what we need to know. Surgery, 170(1), 336–340. https://doi.org/10.1016/j.surg.2021.02.013 - DOI - PubMed
    1. Baker, G. M., Pyle, M. E., Tobias, A. M., Bartlett, R. A., Phillips, J., Fein-Zachary, V. J., Wulf, G. M., & Heng, Y. J. (2019). Establishing a cohort of transgender men and gender nonconforming individuals to understand the molecular impact of testosterone on breast physiology. Transgender Health, 4(1), 326–330. https://doi.org/10.1089/trgh.2019.0040 - DOI - PubMed - PMC
    1. Barghouthi, N., Turner, J., & Perini, J. (2018). Breast cancer development in a transgender male receiving testosterone therapy. Case Reports in Endocrinology, 2018, 3652602. https://doi.org/10.1155/2018/3652602 - DOI - PubMed - PMC
    1. Bentz, E.-K., Pils, D., Bilban, M., Kaufmann, U., Hefler, L. A., Reinthaller, A., Singer, C. F., Huber, J. C., Horvat, R., & Tempfer, C. B. (2010). Gene expression signatures of breast tissue before and after cross-sex hormone therapy in female-to-male transsexuals. Fertility and Sterility, 94(7), 2688–2696. https://doi.org/10.1016/j.fertnstert.2010.04.024 - DOI - PubMed
    1. Boni, C., Pagano, M., Panebianco, M., Bologna, A., Sierra, N. M. A., Gnoni, R., Formisano, D., & Bisagni, G. (2014). Therapeutic activity of testosterone in metastatic breast cancer. Anticancer Research, 34(3), 1287–1290. - PubMed

Publication types

LinkOut - more resources